Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(24)2023 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-38139095

RESUMO

In the shadow of SARS-CoV-2, influenza seems to be an innocent virus, although new zoonotic influenza viruses evolved by mutations may lead to severe pandemics. According to WHO, there is an urgent need for better antiviral drugs. Blocking viral hemagglutinin with multivalent N-acetylneuraminic acid derivatives is a promising approach to prevent influenza infection. Moreover, dual inhibition of both hemagglutinin and neuraminidase may result in a more powerful effect. Since both viral glycoproteins can bind to neuraminic acid, we have prepared three series of amphiphilic self-assembling 2-thio-neuraminic acid derivatives constituting aggregates in aqueous medium to take advantage of their multivalent effect. One of the series was prepared by the azide-alkyne click reaction, and the other two by the thio-click reaction to yield neuraminic acid derivatives containing lipophilic tails of different sizes and an enzymatically stable thioglycosidic bond. Two of the three bis-octyl derivatives produced proved to be active against influenza viruses, while all three octyl derivatives bound to hemagglutinin and neuraminidase from H1N1 and H3N2 influenza types.


Assuntos
Vírus da Influenza A Subtipo H1N1 , Influenza Humana , Humanos , Influenza Humana/tratamento farmacológico , Ácido N-Acetilneuramínico/farmacologia , Ácido N-Acetilneuramínico/metabolismo , Hemaglutininas/farmacologia , Neuraminidase/metabolismo , Vírus da Influenza A Subtipo H3N2 , Ácidos Neuramínicos , Glicoproteínas de Hemaglutininação de Vírus da Influenza/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...